Form 4: Q32 Bio CEO Sells Shares for Tax Obligations

Q32 Bio Inc.'s CEO, Jodie Pope Morrison, sold 9,896 shares of common stock at a weighted average price of $4.5144 to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Jodie Pope Morrison, CEO and Director of Q32 Bio Inc., sold 9,896 shares of common stock.
• The sale occurred on February 25, 2026, at a weighted average price of $4.5144 per share.
• Individual transaction prices ranged from $4.35 to $4.69 per share.
• The sale was mandatory to cover tax withholding obligations associated with the vesting of restricted stock units.
• The transaction was automatic and not at the discretion of the Reporting Person.
• Following the sale, Morrison beneficially owns 89,104 shares of Q32 Bio Inc. common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While it's a sale by an insider, the non-discretionary nature for tax purposes mitigates any negative sentiment typically associated with insider selling.

Positives

• The sale was non-discretionary, solely for tax withholding, indicating it is not a voluntary divestment based on a negative outlook.
• The vesting of restricted stock units implies compensation and retention of key management.

Negatives

• A reduction in direct beneficial ownership by a key executive, even if for tax purposes, slightly decreases their direct equity stake.

Future Outlook

NA

Management Comments

• Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• These sales were automatic and not in the discretion of the Reporting Person.

Industry Context

StockSavvy.ai notes that routine insider sales for tax withholding purposes, such as those related to restricted stock unit vesting, are common across all industries and typically do not signal a change in management's confidence in the company's prospects. This is a standard compensation-related event.

Stakeholder Impact

• Shareholders: Minimal direct impact as it is a routine, non-discretionary sale for tax purposes, not indicative of a change in company fundamentals or management's outlook.

Key Dates

Recommendation

The transaction is a routine, non-discretionary sale by the CEO to cover tax obligations upon the vesting of restricted stock units. It does not reflect a change in the CEO's confidence in the company or its future prospects, nor does it provide new fundamental information to warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event is neutral.

Keywords

Q32 Bio Inc., QTTB, Jodie Pope Morrison, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, CEO, Director